Y-Intercept Hong Kong Investment Activity in Q2 2026

Y-Intercept (Hong Kong) Ltd demonstrated significant activity in its portfolio during Q2 2026. The investor engaged in both buying and selling activities, impacting holdings across multiple sectors including Technology, Financial Services, Healthcare, Consumer Cyclical, and others.

Tech Sector Focus

The investment firm showed a strong inclination towards the Technology sector this quarter. Notably, it increased its stake significantly in several key players:

• AMZN (Amazon.com Inc.), adding over half a million shares (+261,543%, representing an increase in allocation from the previous period's basis).
• CRM (Salesforce Inc.), acquiring a substantial number of shares (+259.01%, significantly boosting its portfolio allocation to 0.7%).
• CME (CME Group Inc.), adding shares (+1305.98%, increasing its allocation to 0.65%).
• MSFT (Microsoft Corp.), acquiring a moderate number of shares (+14.87%, increasing allocation to 0.88%).
• CTSH (Cognizant Technology Solutions), adding shares (+404.71%, increasing allocation to 0.61%).

Financial Services Expansion and Reductions

In the Financial Services sector, Y-Intercept Hong Kong Ltd significantly expanded its positions while also reducing exposure in some areas:

• BSX (Boston Scientific Corp.) saw a massive increase, adding nearly half a million shares (+148.81%, increasing allocation to 0.95%).
• OWL (Blue Owl Capital Inc.) experienced a huge jump, acquiring nearly eight hundred thousand shares (+972.54%, increasing allocation to 0.13%).
• KVUE (KenVue Inc.) was added with a significant position, representing 0.4% of the portfolio.
• The investor also sold major holdings in this sector: exiting LRCX (Lucid Motors Inc.) with a large reduction (-92.58%, decreasing allocation to 0.02%).

Mixed Healthcare Activity

The Healthcare sector displayed mixed results for Y-Intercept Hong Kong Ltd:

• BSX (Boston Scientific Corp.) was a major addition, increasing allocation to 0.95%.
• ANNX (Annexon Inc.) saw an increase in shares (+344.64%, increasing allocation to 0.08%).
• FULC (Fulcrum Therapeutics Inc.) was added with a notable increase (+344.64%, increasing allocation to 0.05%).
• ADMA (AdMA BioLogics Inc.) experienced a significant decrease (-46.66%, reducing allocation to 0.1%).

New Consumer Cyclical and Other Additions

The investor broadened its scope beyond Technology with several new or increased positions:

• RIVN (Rivian Automotive Inc.) was added, albeit a small allocation (+0.02%). However, the investor also sold this position drastically later in Q2 (-96.09%, reducing it to 0.02%).
• KVUE (KenVue Inc.) was added with a significant position (+100%, increasing allocation to 0.4%), though this is also within Consumer Defensive.
• PBR (Petroleo Brasileiro S.A.) was added, representing a larger allocation (+962.35%, increasing to 0.22%).
• ALIT (Alight Inc.) was added with a small stake (+1116.97%, increasing allocation to 0.01%).
• TME (Tencent Music Entmt Group) was added with a small stake (+4.27%). However, the investor also sold this position later in Q2 (-70.23%, reducing it to 0.04%).

Conversely, activities were not observed for sectors like Energy (except via PBR) or Basic Materials (ASM). No such activity is disclosed in this filing for the Energy sector beyond PBR, and there was no change indicated for Basic Materials holdings.